$MSLE

$8.97▲ +5.5% YTD

2 SEC 13D/G filings tracked · Last updated Sep 24, 2026

Filing History

CP $8.97▲ +5.5%Sep 24, 2026 · ThinkSabio Blog

$MSLE - Satellos Announces FDA Clearance of IND Application for Forazapadin in Facioscapulohumeral Muscular Dystrophy (FSHD) and a Partnership with FS…

News

MSLE ▼ -0.8% - Satellos Bioscience Inc.

CP $9.34▲ -0.8%Sep 1, 2026 · ThinkSabio Blog

$MSLE - Satellos to Participate in Upcoming Investor Conferences…